AUCTUS Capital exits PharmaLex to AmerisourceBergen

AmerisourceBergen is expected to pay €1.28 billion in cash for the firm.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this